In addition to neurodegenerative diseases, inhibition of the cGAS/STING/NLRP3 signaling pathway can also improve neonatal hypoxic-ischemic encephalopathy and cerebral venous sinus thrombosis (31, 32). Here, NLRP3 is linked to neurodegenerative disease.